Figure 1
Cumulative incidence of fatal and nonfatal thrombotic events versus deaths from other causes (competing risk analysis) in 707 patients with primary myelofibrosis.
Cumulative incidence of fatal and nonfatal thrombotic events versus deaths from other causes (competing risk analysis) in 707 patients with primary myelofibrosis.
